Cite
Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies.
MLA
Roskams-Hieter, Breeshey, et al. “Plasma Cell-Free RNA Profiling Distinguishes Cancers from Pre-Malignant Conditions in Solid and Hematologic Malignancies.” NPJ Precision Oncology, vol. 6, no. 1, Apr. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1038/s41698-022-00270-y.
APA
Roskams-Hieter, B., Kim, H. J., Anur, P., Wagner, J. T., Callahan, R., Spiliotopoulos, E., Kirschbaum, C. W., Civitci, F., Spellman, P. T., Thompson, R. F., Farsad, K., Naugler, W. E., & Ngo, T. T. M. (2022). Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies. NPJ Precision Oncology, 6(1), 1–11. https://doi.org/10.1038/s41698-022-00270-y
Chicago
Roskams-Hieter, Breeshey, Hyun Ji Kim, Pavana Anur, Josiah T. Wagner, Rowan Callahan, Elias Spiliotopoulos, Charles Ward Kirschbaum, et al. 2022. “Plasma Cell-Free RNA Profiling Distinguishes Cancers from Pre-Malignant Conditions in Solid and Hematologic Malignancies.” NPJ Precision Oncology 6 (1): 1–11. doi:10.1038/s41698-022-00270-y.